CLRB
Price
$3.98
Change
+$0.35 (+9.64%)
Updated
Mar 28, 6:59 PM EST
38 days until earnings call
MORF
Price
$35.20
Change
+$0.81 (+2.36%)
Updated
Mar 28, 6:59 PM EST
26 days until earnings call
Ad is loading...

CLRB vs MORF ᐉ Comparison: Which is Better to Invest?

Header iconCLRB vs MORF Comparison
Open Charts CLRB vs MORFBanner chart's image
Cellectar Biosciences
Price$3.98
Change+$0.35 (+9.64%)
Volume$1.15M
CapitalizationN/A
Morphic Holding
Price$35.20
Change+$0.81 (+2.36%)
Volume$182.95K
CapitalizationN/A
View a ticker or compare two or three
CLRB vs MORF Comparison Chart

Loading...

CLRBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MORFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CLRB vs. MORF commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a Buy and MORF is a Buy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (CLRB: $3.98 vs. MORF: $35.12)
Brand notoriety: CLRB and MORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 151% vs. MORF: 54%
Market capitalization -- CLRB: $48.91M vs. MORF: $1.76B
CLRB [@Biotechnology] is valued at $48.91M. MORF’s [@Biotechnology] market capitalization is $1.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green whileMORF’s FA Score has 0 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • MORF’s FA Score: 0 green, 5 red.
According to our system of comparison, CLRB is a better buy in the long-term than MORF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 5 TA indicator(s) are bullish while MORF’s TA Score has 4 bullish TA indicator(s).

  • CLRB’s TA Score: 5 bullish, 5 bearish.
  • MORF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MORF is a better buy in the short-term than CLRB.

Price Growth

CLRB (@Biotechnology) experienced а +2.84% price change this week, while MORF (@Biotechnology) price change was +1.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

CLRB is expected to report earnings on May 06, 2024.

MORF is expected to report earnings on Apr 24, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CLRB with price predictions.
OPEN
A.I.dvisor published
a Summary for MORF with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MORF($1.76B) has a higher market cap than CLRB($48.9M). CLRB YTD gains are higher at: 43.682 vs. MORF (21.607). CLRB has higher annual earnings (EBITDA): -33.67M vs. MORF (-177.6M). MORF has more cash in the bank: 704M vs. CLRB (19M). CLRB has less debt than MORF: CLRB (569K) vs MORF (2.34M). MORF has higher revenues than CLRB: MORF (521K) vs CLRB (0).
CLRBMORFCLRB / MORF
Capitalization48.9M1.76B3%
EBITDA-33.67M-177.6M19%
Gain YTD43.68221.607202%
P/E RatioN/AN/A-
Revenue0521K-
Total Cash19M704M3%
Total Debt569K2.34M24%
FUNDAMENTALS RATINGS
CLRB: Fundamental Ratings
CLRB
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLRBMORF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
CLRBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MORFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEXN5.220.08
+1.56%
Nexxen International Ltd
G32.950.19
+0.58%
Genpact Limited
ADP249.651.32
+0.53%
Automatic Data Processing
CAL41.03-0.06
-0.15%
Caleres
KPLT11.53-0.12
-1.03%
Katapult Holdings

MORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MORF has been loosely correlated with ORMP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MORF jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MORF
1D Price
Change %
MORF100%
+2.12%
ORMP - MORF
45%
Loosely correlated
+3.55%
AXON - MORF
43%
Loosely correlated
-0.98%
ARRY - MORF
42%
Loosely correlated
-1.26%
SRPT - MORF
42%
Loosely correlated
-0.57%
PCVX - MORF
41%
Loosely correlated
-0.39%
More